Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 256251, 10 pages
http://dx.doi.org/10.1155/2008/256251
Review Article

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

Department of Laboratory Medicine, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy

Received 26 March 2008; Revised 27 May 2008; Accepted 18 June 2008

Academic Editor: Dipak Panigrahy

Copyright © 2008 Roberto Scatena et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [33 citations]

The following is the list of published articles that have cited the current article.

  • Paras K. Mishra, Neetu Tyagi, Utpal Sen, Irving G. Joshua, and Suresh C. Tyagi, “Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol,” Cardiovascular Diabetology, vol. 9, 2010. View at PublisherView at Google Scholar
  • Michaela Luconi, Giulia Cantini, and Mario Serio, “Peroxisome proliferator-activated receptor gamma (PPARγ): Is the genomic activity the only answer?,” Steroids, vol. 75, no. 8-9, pp. 585–594, 2010. View at PublisherView at Google Scholar
  • Justyna Drukala, Katarzyna Urbanska, Anna Wilk, Maja Grabacka, Ewa Wybieralska, Luis Del Valle, Zbigniew Madeja, and Krzysztof Reiss, “ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPAR alpha -mediated inhibition of Glioma cell motility in vitro,” Molecular Cancer, vol. 9, 2010. View at PublisherView at Google Scholar
  • Aiqin Cao, Hai Li, Yue Zhou, Minhao Wu, and Jingwen Liu, “Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor δ in HepG2 hepatoma cells,” Journal of Biological Chemistry, vol. 285, no. 22, pp. 16664–16674, 2010. View at PublisherView at Google Scholar
  • Stephen J. Ralph, Sara Rodríguez-Enríquez, Jiri Neuzil, and Rafael Moreno-Sánchez, “Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger,” Molecular Aspects of Medicine, vol. 31, no. 1, pp. 29–59, 2010. View at PublisherView at Google Scholar
  • Penna, Bonelli, Baccino, and Costelli, “Cytotoxic properties of clofibrate and other peroxisome proliferators: Relevance to cancer progression,” Current Medicinal Chemistry, vol. 17, no. 4, pp. 309–320, 2010. View at PublisherView at Google Scholar
  • Michelle C. Sangar, Seema Bansal, and Narayan C. Avadhani, “Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity,” Expert Opinion On Drug Metabolism & Toxicology, vol. 6, no. 10, pp. 1231–1251, 2010. View at PublisherView at Google Scholar
  • Ewa Wybieralska, Katarzyna Szpak, Andrzej Gorecki, Piotr Bonarek, Katarzyna Miekus, Justyna Drukala, Marcin Majka, Krzysztof Reiss, Zbigniew Madeja, and Jaroslaw Czyz, “Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations,” Oncology Reports, vol. 26, no. 2, pp. 447–453, 2011. View at PublisherView at Google Scholar
  • Roberto Scatena, Patrizia Bottoni, Alessandro Pontoglio, and Bruno Giardina, “Cancer stem cells: the development of new cancer therapeutics,” Expert Opinion on Biological Therapy, vol. 11, no. 7, pp. 875–892, 2011. View at PublisherView at Google Scholar
  • Chun-Xia Yao, Wen-Yan Li, Shu-Feng Zhang, Shan-Feng Zhang, Hai-Feng Zhang, and Ming-Xi Zang, “Effects of Doxorubicin and Fenofibrate on the Activities of NADH Oxidase and Citrate Synthase in Mice,” Basic & Clinical Pharmacology & Toxicology, vol. 109, no. 6, pp. 452–456, 2011. View at PublisherView at Google Scholar
  • Fabio Penna, Fabrizio Pin, Domiziana Costamagna, Patrizia Reffo, Francesco Maria Baccino, Gabriella Bonelli, and Paola Costelli, “Caspase 2 Activation and ER Stress Drive Rapid Jurkat Cell Apoptosis by Clofibrate,” Plos One, vol. 7, no. 9, 2012. View at PublisherView at Google Scholar
  • Inês A. Barbosa, Nuno G. Machado, Andrew J. Skildum, Patricia M. Scott, and Paulo J. Oliveira, “Mitochondrial remodeling in cancer metabolism and survival: Potential for new therapies,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1826, no. 1, pp. 238–254, 2012. View at PublisherView at Google Scholar
  • Roberto Scatena, “Mitochondria and drugs,” Advances in Experimental Medicine and Biology, vol. 942, pp. 329–346, 2012. View at PublisherView at Google Scholar
  • Joseph Vamecq, Jean-Marie Colet, Jean Jacques Vanden Eynde, Gilbert Briand, Nicole Porchet, and Stéphane Rocchi, “PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials,” PPAR Research, vol. 2012, pp. 1–23, 2012. View at PublisherView at Google Scholar
  • Lina Sabatino, Alessandra Fucci, Massimo Pancione, and Vittorio Colantuoni, “PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis,” PPAR Research, vol. 2012, pp. 1–12, 2012. View at PublisherView at Google Scholar
  • Roberto Scatena, Patrizia Bottoni, Alessandro Pontoglio, Salvatore Scarà, and Bruno Giardinapp. 239–266, 2013. View at PublisherView at Google Scholar
  • Yu-Chun Huang, Kao-Chih Liu, Yi-Ling Chiou, Chao-Hsun Yang, Tien-Hui Chen, Ting-Ting Li, and Li-Ling Liu, “Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway,” Chemico-Biological Interactions, 2013. View at PublisherView at Google Scholar
  • Jihan A. Youssef, Mostafa Z. Badr, Jihan A. Youssef, and Mostafa Z. Badr, “Tissue Distribution and Versatile Functions of PPARs,” Peroxisome Proliferator-Activated Receptors, pp. 33–69, 2013. View at PublisherView at Google Scholar
  • Jihan A. Youssef, Mostafa Z. Badr, Jihan A. Youssef, and Mostafa Z. Badr, “Molecular Aspects of PPAR Actions,” Peroxisome Proliferator-Activated Receptors, pp. 79–83, 2013. View at PublisherView at Google Scholar
  • Malgorzata Pierzchalska, Krzysztof Reiss, and Maja Grabacka, “Peroxisome Proliferator Activated Receptor alpha Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism,” Current Pharmaceutical Biotechnology, vol. 14, no. 3, pp. 342–356, 2013. View at PublisherView at Google Scholar
  • Jihan A. Youssef, and Mostafa Z. Badrpp. 1–137, 2013. View at PublisherView at Google Scholar
  • Katarzyna Piwowarczyk, Ewa Wybieralska, Jarosław Baran, Julia Borowczyk, Paulina Rybak, Milena Kosińska, Anna Julia Włodarczyk, Marta Michalik, Maciej Siedlar, Zbigniew Madeja, Jerzy Dobrucki, Krzysztof Reiss, and Jarosław Czyż, “Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells,” Expert Opinion on Therapeutic Targets, pp. 1–14, 2014. View at PublisherView at Google Scholar
  • Li-Guo Xing, and Ying-Liang Wu, “Progress of carcinogenesis and possible mechanisms of peroxisome proliferator-activated receptor agonists,” Chinese Journal of Pharmacology and Toxicology, vol. 28, no. 3, pp. 455–461, 2014. View at PublisherView at Google Scholar
  • M. Jiang, and N. Yang, “Peroxisome Proliferators,” Encyclopedia of Toxicology, pp. 815–819, 2014. View at PublisherView at Google Scholar
  • Dongfeng Han, Ning Liu, Yongping You, Wenjin Wei, Xincheng Chen, Yaxuan Zhang, Yingyi Wang, Junxia Zhang, Xiefeng Wang, Tianfu Yu, and Qi Hu, “NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells,” Oncotarget, vol. 6, no. 28, pp. 26119–26128, 2015. View at PublisherView at Google Scholar
  • Konrad A. Szychowski, Marcin L. Leja, Danylo V. Kaminskyy, Anna P. Kryshchyshyn, Urszula E. Binduga, Oleh R. Pinyazhko, Roman B. Lesyk, Jakub Tobiasz, and Jan Gmiński, “Peroxisome proliferator-activated receptor gamma (PPARγ)–dependent mechanism of action in anticancer 4-thiazolidinone derivatives,” European Journal of Medicinal Chemistry, 2017. View at PublisherView at Google Scholar
  • Shaomin Zou, Lekun Fang, and Mong-Hong Lee, “Dysbiosis of gut microbiota in promoting the development of colorectal cancer,” Gastroenterology Report, vol. 6, no. 1, pp. 1–12, 2017. View at PublisherView at Google Scholar
  • Katarzyna Piwowarczyk, Edyta Kwiecień, Justyna Sośniak, Eliza Zimoląg, Emiliana Guzik, Jolanta Sroka, Zbigniew Madeja, and Jarosław Czyż, “Fenofibrate Interferes with the Diapedesis of Lung Adenocarcinoma Cells through the Interference with Cx43/EGF-Dependent Intercellular Signaling,” Cancers, vol. 10, no. 10, pp. 363, 2018. View at PublisherView at Google Scholar
  • Shreekrishna Lamichane, Babita Dahal Lamichane, and Sang-Mo Kwon, “Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis,” International Journal of Molecular Sciences, vol. 19, no. 4, pp. 949, 2018. View at PublisherView at Google Scholar
  • J. Stalinska, E. Zimolag, Na. Pianovich, A. Zapata, A. Lassak, M. Rak, M. Dean, D. Ucar-Bilyeu, D. Wyczechowska, F. Culicchia, L. Marrero, L. Del Valle, J. Sarkaria, F. Peruzzi, Bs Jursic, and K. Reiss, “Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential,” Translational Oncology, vol. 12, no. 7, pp. 895–907, 2019. View at PublisherView at Google Scholar
  • Gang Wang, Yang Yu, Yu‐Zhu Wang, Jun‐Jie Wang, Rui Guan, Yan Sun, Feng Shi, Jing Gao, and Xing‐Li Fu, “Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy,” Journal of Cellular Physiology, 2019. View at PublisherView at Google Scholar
  • Agha Zeeshan Mirza, Ismail I. Althagafi, and Hina Shamshad, “Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications,” European Journal of Medicinal Chemistry, 2019. View at PublisherView at Google Scholar
  • Marcin Luty, Katarzyna Piwowarczyk, Anna Łabędź-Masłowska, Tomasz Wróbel, Małgorzata Szczygieł, Jessica Catapano, Grażyna Drabik, Damian Ryszawy, Sylwia Kędracka-Krok, Zbigniew Madeja, Maciej Siedlar, Martyna Elas, and Jarosław Czyż, “Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel,” Cancers, vol. 11, no. 1, pp. 77, 2019. View at PublisherView at Google Scholar